Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-Regulatory factor 1-dependent domains in the CD95 ligand promoter

被引:50
作者
Kirchhoff, S
Sebens, T
Baumann, S
Krueger, A
Zawatzky, R
Min, LW
Meinl, E
Neipel, F
Fleckenstein, B
Krammer, PH
机构
[1] German Canc Res Ctr, Div Immunogenet G0300, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Tumor Immunol Program, D-69120 Heidelberg, Germany
[3] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany
[4] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany
[5] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany
关键词
D O I
10.4049/jimmunol.168.3.1226
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD95 (also called APO-1/Fas) system plays a major role in the induction of apoptosis in lymphoid and nonlymphoid tissues. The CD95 ligand (CD95L) is induced in response to a variety of signals, including IFN-gamma and TCR/CD3 stimulation. Here we report the identification of two positive regulatory IFN-regulatory factor-dependent domains (PRIDDs) in the CD95L promoter and its 5' untranslated region, respectively. EMSAs demonstrate specific binding of IFN-gamma-induced IFN-regulatory factor I (IRF-1) to the PRIDD sequences. Ectopic IRF-1 expression induces CD95L promoter activity. Furthermore, we demonstrate that PRIDDs play an important role in TCR/CD3-mediated CD95L induction. Most interestingly, viral IRFs of human herpes virus 8 (HHV8) totally abolish IPF-1-mediated and strongly reduce TCR/CD3-mediated CD95L induction. We demonstrate here for the first time that viral IRFs inhibit activation-induced cell death. Thus, these results demonstrate an important mechanism of HHV8 to modulate the immune response by down-regulation of CD95L expression. Inhibition of CD95-dependent T cell function might contribute to the immune escape of HHV8.
引用
收藏
页码:1226 / 1234
页数:9
相关论文
共 68 条
[31]  
Latinis KM, 1997, J IMMUNOL, V158, P4602
[32]   Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor [J].
Li, M ;
Damania, B ;
Alvarez, X ;
Ogryzko, V ;
Ozato, K ;
Jung, JU .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) :8254-8263
[33]   Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor [J].
Li, MT ;
Lee, H ;
Guo, J ;
Neipel, F ;
Fleckenstein, B ;
Ozato, K ;
Jung, JU .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5433-5440
[34]  
Li-Weber M, 2000, EUR J IMMUNOL, V30, P661, DOI 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO
[35]  
2-L
[36]  
Li-Weber M, 1998, EUR J IMMUNOL, V28, P2373, DOI 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO
[37]  
2-T
[38]  
Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO
[39]  
2-R
[40]   Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28 [J].
Li-Weber, M ;
Giasi, M ;
Krammer, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32460-32466